ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI 1985 Bypass Budget By Groups

May 20, 1983

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

Panel May Take On OMB In Battle to Restore NCI Construction Funds; Two Will Be Funded In FY ‘83

November 12, 1982

ACS Awards Medals to Holland, Sporn, RWJ Foundation

December 2, 1994

Grossman Leads Neuro-Oncology Society; NYU Recruits Radiation Oncology Director.

January 14, 2000

Possible Budget Balancing Effort Darkens Prospect For Increase In Cancer Budget

March 7, 1980